Acquiring Company
CBD of Denver
Acquired Company
BioCannabis M. IKE
Denver
GreeceHealth CareCannabisHealth CareDietary SupplementsFitnessWellnessDescription
CBD of Denver, Inc. has signed a definitive Share Exchange Agreement to acquire BioCannabis M. IKE. This acquisition marks a strategic expansion into the global wellness market, projected to reach $9.8 trillion by 2029. It will provide CBD of Denver with new operational foundations and market opportunities in Europe. Further details will be disclosed as the deal progresses through regulatory approvals.
Quick answer
CBD of Denver is acquiring BioCannabis M. IKE, announced September 15, 2026. CBD of Denver is based in Denver, Colorado, United States.
- How much did CBD of Denver pay for BioCannabis M. IKE?
- The deal value was not disclosed.
- What does CBD of Denver do?
- CBD of Denver, Inc. operates in the hemp and cannabis market.
- Where are CBD of Denver and BioCannabis M. IKE based?
- CBD of Denver is based in Denver, Colorado, United States. BioCannabis M. IKE is based in Greece.
Source: Fundz verified event record.
Who to call at CBD of Denver, and when
When CBD of Denver changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CBD of Denver raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CBD of Denver, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CBD of Denver. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CBD of Denver makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired BioCannabis M. IKE?
BioCannabis M. IKE was acquired by CBD of Denver, based in Denver. The deal was reported on September 15, 2026. CBD of Denver, Inc. operates in the hemp and cannabis market. The company focuses on delivering high-quality CBD products. They aim to promote health and wellness through their product offerings. CBD of Denver is privately held and operates in Health Care.
When did CBD of Denver acquire BioCannabis M. IKE?
CBD of Denver's acquisition of BioCannabis M. IKE was reported on September 15, 2026. CBD of Denver, Inc. has signed a definitive Share Exchange Agreement to acquire BioCannabis M. IKE. This acquisition marks a strategic expansion into the global wellness market, projected to reach $9.8 trillion by 2029. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BioCannabis M. IKE do?
BioCannabis M. IKE is a health and wellness company based in Greece. They specialize in developing cannabis-based products for health improvement. Their commitment is towards leveraging natural ingredients for wellness purposes. It is privately held, operating in Health Care, and is based in Greece.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.